title: Interleukin-2: a potential treatment option for postherpetic neuralgia?
abstract: Postherpetic neuralgia is a chronic pain syndrome that is often difficult to treat and can lead to a disabling disease if it is resistant to therapy. Presented here is the case of a 46-year-old patient with human immunodeficiency virus infection and chronic, treatment-resistant neuralgia. Postherpetic pain resolved after treatment with 1 cycle of subcutaneous recombinant interleukin-2.
authors.affiliation: Department of Infectious Diseases and Pulmonary Medicine, Charite University Hospital Berlin, Berlin, 13353, Germany. Jessica.Rotty@charite.de
authors.forename: Jessica
authors.initials: J
authors.lastname: Rotty
authors.forename: Lucie
authors.initials: L
authors.lastname: Heinzerling
authors.forename: Dirk
authors.initials: D
authors.lastname: Schurmann
authors.forename: Norbert
authors.initials: N
authors.lastname: Suttorp
mesh_terms: D000700:Analgesics / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D051474:Neuralgia, Postherpetic / Q000188:drug therapy* / Q000209:etiology; D010146:Pain / Q000188:drug therapy
chemical_list: D000700:Analgesics; D007376:Interleukin-2